# FDA recall D-253-2013

> **Pfizer Inc.** · Class II · drug recall initiated 2013-03-28.

## Product

Levoxyl (levothyroxine sodium) tablets, USP 75 mcg,  packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles ( NDC 60793-852-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.

## Reason for recall

Chemical contamination: emission of strong odor after package was opened.

## Distribution

Nationwide and PR

## Key facts

- **Recall number:** D-253-2013
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2013-03-28
- **Report date:** 2013-04-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-253-2013

## Citation

> AI Analytics. FDA recall D-253-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-253-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*